These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 32098873)
21. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
23. Structure-function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk. Gkolfinopoulou C; Soukou F; Dafnis I; Kellici TF; Sanoudou D; Mavromoustakos T; Stratikos E; Chroni A Cell Mol Life Sci; 2021 Feb; 78(4):1523-1544. PubMed ID: 32666307 [TBL] [Abstract][Full Text] [Related]
24. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294 [TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1. Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA FASEB J; 2019 Jul; 33(7):8479-8489. PubMed ID: 30970222 [TBL] [Abstract][Full Text] [Related]
26. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721 [TBL] [Abstract][Full Text] [Related]
27. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770 [TBL] [Abstract][Full Text] [Related]
28. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Rosenblat M; Vaya J; Shih D; Aviram M Atherosclerosis; 2005 Mar; 179(1):69-77. PubMed ID: 15721011 [TBL] [Abstract][Full Text] [Related]
29. Current models of apolipoprotein A-I lipidation by adenosine triphosphate binding cassette transporter A1. Hafiane A; Gianopoulos I; Sorci-Thomas MG; Daskalopoulou SS Curr Opin Lipidol; 2022 Apr; 33(2):139-145. PubMed ID: 34581311 [TBL] [Abstract][Full Text] [Related]
30. Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models. Zannis VI; Koukos G; Drosatos K; Vezeridis A; Zanni EE; Kypreos KE; Chroni A Ann Med; 2008; 40 Suppl 1():14-28. PubMed ID: 18246469 [TBL] [Abstract][Full Text] [Related]
31. Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I. Hossain MA; Ngeth S; Chan T; Oda MN; Francis GA BMC Biochem; 2012 Jan; 13():1. PubMed ID: 22248050 [TBL] [Abstract][Full Text] [Related]
32. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246 [TBL] [Abstract][Full Text] [Related]
33. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. Zannis VI; Chroni A; Krieger M J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936 [TBL] [Abstract][Full Text] [Related]
34. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. Shao B; Tang C; Heinecke JW; Oram JF J Lipid Res; 2010 Jul; 51(7):1849-58. PubMed ID: 20064972 [TBL] [Abstract][Full Text] [Related]
35. ABCA1 and nascent HDL biogenesis. Wang S; Smith JD Biofactors; 2014; 40(6):547-54. PubMed ID: 25359426 [TBL] [Abstract][Full Text] [Related]
37. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556 [TBL] [Abstract][Full Text] [Related]
38. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. Shao B; Pennathur S; Heinecke JW J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194 [TBL] [Abstract][Full Text] [Related]
39. Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages. Tang C; Houston BA; Storey C; LeBoeuf RC J Lipid Res; 2016 May; 57(5):848-57. PubMed ID: 26989082 [TBL] [Abstract][Full Text] [Related]
40. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]